SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Changing the Status of Drugs from Prescription to Over-the-Counter Availability
0 references·5 citing·14 second hop
Changing the Status of Drugs from Prescription to Over-the-Counter Availability (2001)Changing the Status of Drugs from Prescri…Andersen Model (2021)Andersen ModelAndersen Model (2021)Andersen ModelThe value of self-medication: summary of existing evidence (2017)The value of self-medication:…Patent cliff and strategic switch: exploring strategic design possibilities in the pharmaceutical industry (2016)Patent cliff and strategic sw…Regulating pharmaceuticals in Europe : striving for efficiency, equity and quality (2004)Regulating pharmaceuticals in…The economics of moral hazard: comment (1982)The price of innovation: new estimates of drug development costs (2003)UNCERTAINTY AND THE WELFARE ECONOMICS OF MEDICAL CARE (2003)Competition in off-patent drug markets: Issues, regulation and evidence (2008)What impact do prescription drug charges have on efficiency and equity? Evidence from high-income countries (2008)Pharmaceutical policies in European countries in response to the global financial crisis (2011)Business Models, Business Strategy and Innovation (2009)How to improve R&D productivity: the pharmaceutical industry's grand challenge (2010)The Business Model: Recent Developments and Future Research (2011)Impact of China’s drug innovation policy on patent quantity and quality: Evidence from a representative chemical pharmaceutical enterprise (2025)Access to Care Is the Centerpiece in the Elimination of Socioeconomic Disparities in Health (1998)Societal and Individual Determinants of Medical Care Utilization in the United States (1973)Revisiting the Behavioral Model and Access to Medical Care: Does it Matter? (1995)National Health Surveys and the Behavioral Model of Health Services Use (2008)
this work references cited by second hop

References

No references inside the corpus for this window.

Cited by

  • 2004Regulating pharmaceuticals in Europe : striving for efficiency, equity and quality162 cited
  • 2017The value of self-medication: summary of existing evidence125 cited
  • 2016Patent cliff and strategic switch: exploring strategic design possibilities in the pharmaceutical industry60 cited
  • 2021Andersen Model9 cited
  • 2021Andersen Model2 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work